Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$13.31 - $20.51 $1.9 Million - $2.93 Million
-143,050 Closed
0 $0
Q1 2020

May 05, 2020

BUY
$12.98 - $30.25 $283,613 - $660,962
21,850 Added 18.03%
143,050 $2.22 Million
Q4 2019

Feb 10, 2020

SELL
$18.89 - $31.89 $21.3 Million - $36 Million
-1,127,390 Reduced 90.29%
121,200 $3.63 Million
Q3 2019

Nov 12, 2019

SELL
$20.88 - $25.66 $5.57 Million - $6.84 Million
-266,625 Reduced 17.6%
1,248,590 $27.3 Million
Q2 2019

Aug 12, 2019

BUY
$20.52 - $26.45 $16.5 Million - $21.2 Million
801,760 Added 112.38%
1,515,215 $38.2 Million
Q1 2019

May 14, 2019

BUY
$20.23 - $26.29 $14.4 Million - $18.8 Million
713,455 New
713,455 $17.6 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.59B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Cannell & Co. Portfolio

Follow Cannell & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.